Rallybio Financial Overview
Rallybio's market cap is currently $33.10M. The company's EPS TTM is $0.36; its P/E ratio is -2.37; Rallybio is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
